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CARBONIC ANHYDRASE (carbonic hydrolase; E.C. 4.2.1.1) catalyzes the reversible dehydration of HCO 3 Ϫ in solution. Several isoforms of this zinc metalloenzyme have been described. They differ from one another by their kinetic properties, sensitivity to various inhibitors such as acetazolamide, and subcellular localization (9, 18) . A recent report (19) has drawn attention to the presence in rat pancreatic insulin-producing cells of the mitochondrial carbonic anhydrase isoenzyme V. On the basis of the inhibition of glucose-stimulated insulin secretion by acetazolamide, it was proposed that carbonic anhydrase V may be functionally linked to the regulation of insulin release (19) , either by providing HCO 3 Ϫ for pyruvate carboxylase, which is thought to participate in a pyruvatemalate shuttle, itself considered as the major means for generating cytosolic NADPH from the metabolism of D-glucose in the islet cells (11) , or by regulation of mitochondrial Ca 2ϩ concentration, which is known to increase in glucose-stimulated INS-1 cells (8) .
The major aims of the present study were to provide quantitative information on the activity of carbonic anhydrase in rat pancreatic islet homogenates and to compare it, as well as its sensitivity to acetazolamide, with those found in rat parotid cell homogenates and to evaluate the effects of acetazolamide on secretory, metabolic, ionic, and electrical events in intact pancreatic islets or islet ␤-cells.
MATERIALS AND METHODS
Female Wistar rats (Iffa Credo, L'Arbresle, France) were given free access to food (KM-04-k12; Pavan Service, Oud Turnhout, Belgium) and tap water up to the time of death. This study was approved by the Animal Care and Use Committee of the Université Libre de Bruxelles (Brussels, Belgium).
Pancreatic islets (14) , purified B and non-B islet cells (7) , and parotid cells (15) were prepared by methods described in the cited references.
For measurement of carbonic anhydrase activity, pancreatic islets and parotid cells were ultrasonicated in 50 mM HEPES buffer (pH 8.1). An aliquot (50 l) of the homogenate (from 30 to 60 islets or from 50 to 250 ϫ 10 3 cells per assay) was placed in a glass microtube kept in a plugged scintillation vial. The reaction was started by injection of 50 l of a 100 M or 1.0 mM solution of bicarbonate, which was mixed with a tracer amount of H 14 CO 3 Ϫ into the microtube. After a 3-to 9-min incubation at 20°C, the reaction was stopped by injection of 1 M NaOH (50 l) into the microtube.
14 CO2 was then trapped by hyamin hydroxide (500 l) injected into the vial bottom. After 60 min, the assay tube was removed from the vial and scintillation liquid was added for radioactivity counting.
In homogenates of parotid cells or pancreatic islets, the protein content was measured by the method of Lowry et al. (10) . The methods used to measure insulin release (14) and D-glucose metabolism (13) in isolated rat pancreatic islets were identical to those described in the cited references.
For measurement of H 14 CO 3 Ϫ production by isolated rat islets, groups of 60 islets each were incubated for 90 min at 37°C in 0.1 ml of a HEPES-and bicarbonate-buffered medium (12) containing Dglucose (16.7 mM) mixed with a tracer amount of D-[U-
14 C]glucose (4.0 Ci/ml) in Eppendorf tubes (1.5 ml), which were themselves placed in counting vials (20 ml) . At the end of incubation, the vials were opened to eliminate over 10 min at room temperature the 14 CO2 formed during incubation. NaOH (0.1 ml; 0.1 M) was then added to each tube, and the islets were sonicated (3 ϫ 10 s). The islet homogenates were then transferred on Pasteur pipettes containing 1.0 ml of AG1X8 resin. The tubes were washed twice with 0.5 ml H2O, which was also placed on the column. The column was then washed with distilled water (5 ϫ 1.0 ml), and the H 14 CO 3 Ϫ was eventually eluted with 3.0 ml of 0.3 M NaCl. This eluate was placed in a vial, together with a glass tube containing 0.5 ml of hyamine hydroxide. After vials were closed with rubber covers, 0.1 ml HCl (0.1 M) was injected in each vial, and 14 CO2 was collected over 30 min at 37°C. Control samples (no islets) and reference solutions of H 14 CO 3 Ϫ (0.2 Ci/ml), prepared in the HEPES-and bicarbonatebuffered incubation medium and used to evaluate the recovery of H 14 CO 3 Ϫ (51.6 Ϯ 3.7%; n ϭ 7) under these experimental conditions, were treated in the same manner.
Electrophysiological experiments and intracellular pH measurements were carried out with dispersed rat islet cells, prepared essentially as described previously (2) and cultured for 2-10 days in MEM supplemented with 5% (vol/vol) FCS. ␤-cells were identified by their size, granular appearance, and electrical response to increased concentrations of D-glucose.
␤-Cell membrane potential was monitored with the perforatedpatch configuration of the patch-clamp technique, as described previously (2) . Activity of the volume-sensitive anion channel was assessed from conventional whole cell recordings (3) . Briefly, the cells were voltage clamped at 0 mV and subjected to 200-ms voltage pulses of Ϯ100 mV at 4-s intervals. A hypertonic CsCl-rich pipette solution was used to activate the channel.
Intracellular pH was assessed from the 500 nm-to-450 nm fluorescence ratio in cells loaded with the pH-sensitive dye BCECF (5). Cytosolic Ca 2ϩ concentration ([Ca 2ϩ ]i) was measured as previously described (20) .
All results are presented as means Ϯ SE together with the number of individual determinations (n). The statistical significance of differences between mean values was assessed by Student's t-test.
RESULTS
Enzymatic data. As illustrated in Fig. 1 , top, the generation of 14 CO 2 in the assay of islet carbonic anhydrase was proportional to both the length of incubation (3, 6 , and 9 min) and the number of islets (30, 48, and 60 islets) with respective variation coefficients of 6.1% (n ϭ 15) and 6.3% (n ϭ 9). In the experiments illustrated in Fig. 1 , top, the absolute value for reaction velocity averaged, at 50 M HCO 3 Ϫ , 335 Ϯ 18 fmol⅐min Ϫ1 ⅐islet Ϫ1 (n ϭ 9). At the same HCO 3 Ϫ concentration, as little as 25 M acetazolamide decreased the reaction velocity by 50.1 Ϯ 7.2% (n ϭ 3; P Ͻ 0.025) of paired control value (Fig. 1, bottom) . The residual value for reaction velocity was not significantly different at 25, 50, 100, or 200 M acetazolamide, with an overall mean value for the relative extent of acetazolamide inhibition representing 56.3 Ϯ 3.9% (n ϭ 20; P Ͻ 0.001) of the paired control reaction velocity (420 Ϯ 67 fmol⅐min Ϫ1 ⅐islet Ϫ1 ; n ϭ 7). Essentially comparable results were obtained at a HCO 3 Ϫ concentration of 0.5 mM, with the residual value for reaction velocity averaging in the presence of 50 -200 M acetazolamide 20.3 Ϯ 6.1% (n ϭ 8; P Ͻ 0.001) of the paired control value (5.71 Ϯ 1.75 pmol⅐min Ϫ1 ⅐islet Ϫ1 ; n ϭ 4). NaN 3 (0.05 mM) also inhibited carbonic anhydrase activity in islet homogenates incubated in the presence of 0.5 mM HCO 3 Ϫ by 30.7 Ϯ 3.9% (n ϭ 5; P Ͻ 0.05) of paired control value (6.57 Ϯ 1.25 pmol⅐ min Ϫ1 ⅐islet Ϫ1 ; n ϭ 5). Such an inhibitory action was not enhanced at higher concentrations of NaN 3 . For instance, the relative extent of the decrease in reaction velocity averaged 22.2 Ϯ 3.5% (n ϭ 5; P Ͻ 0.005) of the paired control value at 0.2 mM NaN 3 . When we pooled all available results, the reaction velocity for carbonic anhydrase averaged 372 Ϯ 32 fmol⅐min Ϫ1 ⅐islet Ϫ1 (n ϭ 16) at 50 M HCO 3 Ϫ , compared (P Ͻ 0.001) with 5.10 Ϯ 0.69 pmol⅐min Ϫ1 ⅐islet Ϫ1 (n ϭ 15) at 0.5 mM HCO 3 Ϫ . These mean values are not incompatible (P Ͼ 0.07) with a rule of proportionality between reaction velocity and HCO 3 Ϫ concentration in the range of substrate concentrations under consideration.
Further experiments aimed at comparing the absolute values for carbonic anhydrase activity in purified B vs. non-B islet cell homogenates and in islets vs. parotid cell homogenates and to compare the pattern of acetazolamide inhibitory action on carbonic anhydrase activity in islet vs. parotid cell homogenates.
Relative to cell number, the activity of carbonic anhydrase at 50 M HCO 3 Ϫ was not significantly different (P Ͼ 0.9) in B and non-B islet cells, with an overall mean value of 144 Ϯ 23 amol ⅐ min Ϫ1 ⅐ cell Ϫ1 (n ϭ 6). Assuming a mean number of 2,000 cells per islet, this would correspond to 288 Ϯ 46 fmol ⅐ min Ϫ1 ⅐ islet Ϫ1 , a value not significantly different (P Ͼ 0.25) from that indeed recorded under the same experimental conditions in islet homogenates (335
In the presence of acetazolamide (20 -200 M), the reaction velocity in B and non-B islet cell homogenates was decreased, respectively, by 54.5 Ϯ 9.7% and 41.6 Ϯ 12.9% (n ϭ 6 and P Ͻ 0.025 in both cases) of paired control value (no acetazolamide), which is also in fair agreement with the data recorded in islet homogenates. In parotid cell homogenates, the reaction velocity for carbonic anhydrase was again virtually proportional to HCO 3 Ϫ concentration, increasing (P Ͻ 0.05) from 1.11 Ϯ 0.04 (n ϭ 4) to 11.68 Ϯ 3.01 (n ϭ 8) nmol⅐min Ϫ1 ⅐mg Ϫ1 protein as the concentration of HCO 3 Ϫ was raised from 50 M to 0.5 mM. In the presence of 50 M HCO 3 Ϫ , the activity of the enzyme, expressed per milligram of protein, was four to five times higher (P Ͻ 0.03), however, in parotid cell homogenates than in islet homogenates of the same animals. In these experiments, conducted in the presence of 50 M HCO 3 Ϫ , the control value for carbonic anhydrase activity averaged 216.4 Ϯ 25.4 fmol⅐min Ϫ1 ⅐10 3 cells Ϫ1 (n ϭ 9). The inhibition of carbonic anhydrase in parotid cell homogenates by acetazolamide, as well as by hydrochlorothiazide, represented a concentration-relative phenomenon, with inhibition constant values close to 2.2 and 27.8 M, respectively (Fig. 2) . Acetazolamide in high concentrations (25-200 M) decreased carbonic anhydrase activity, as measured in the presence of 50 M HCO 3 Ϫ , by no more than 56.3 Ϯ 3.9% (n ϭ 20) in islet homogenates and 54.5 Ϯ 9.7% (n ϭ 6) in B islet cell homogenates; however, as little as 10 M acetazolamide decreased the activity of the enzyme at the same concentration of HCO 3 Ϫ by 84.3 Ϯ 3.0% (n ϭ 5) in parotid cell homogenates. Such a difference between islet ␤-cell and parotid cell homogenates, in terms of the maximal relative extent of carbonic anhydrase activity inhibition by acetazolamide, achieved statistical significance (P Ͻ 0.025).
Secretory data. At a low D-glucose concentration (2.8 mM), the output of insulin in the presence of 0.1 and 5.0 mM acetazolamide averaged, respectively, 97.1 Ϯ 13.9 and 119.9 Ϯ 19.5% (n ϭ 30 and P Ͼ 0.3 in both cases) of the mean corresponding value found, within the same experiments, in the absence of acetazolamide (100.0 Ϯ 6.4%; n ϭ 30). Such a reference value represented no more than 39.3 Ϯ 4.4 U/islet per 90 min.
As illustrated in Fig. 3 , NaN 3 (0.03-5.0 mM) caused a concentration-related inhibition of insulin release evoked over 90-min incubation by 16.7 mM D-glucose. In these experiments, the control value for insulin secretion averaged 345.6 Ϯ 29.2 U/islet per 90 min (n ϭ 39). As little as 0.1 mM NaN 3 was sufficient to cause a significant decrease in insulin output (P Ͻ 0.05) relative to the value recorded at 0.03 mM NaN 3 . At the highest concentration of NaN 3 tested in these experiments (5.0 mM), the release of insulin only represented 3.7 Ϯ 2.2% (n ϭ 23) of the mean control value found within the same experiment(s). Low concentrations of acetazolamide (0.03-0.3 mM) tended to augment glucose-induced insulin release; this effect only achieved statistical significance (P Ͻ 0.02) at the lowest drug concentration (0.03 mM). In the concentration range between 0.3 and 10.0 mM, however, acetazolamide progressively decreased the output of insulin (P Ͻ 0.02). In the ranges of concentrations in which the concentration-response relationships illustrated in Fig. 3 could be considered as running in parallel, acetazolamide was ϳ40 times less potent than NaN 3 as an inhibitor of glucose-stimulated insulin release. Hydrochlorothiazide, like acetazolamide, tended to increase insulin output at the lowest concentration of the benzothiadiazide diuretic tested in the present study (1.0 mM). At higher concentrations (3.0 -10.0 mM), however, hydrochlorothiazide caused a concentration-related inhibition of glucose-induced insulin secretion. In the range of concentrations in which the inhibitory action of NaN 3 and hydrochlorothiazide ran in parallel, the latter drug was about nine times less potent than NaN 3 (Fig. 3) . Metabolic data. NaN 3 , when tested in the range from 0.3 to 1.0 mM, failed to affect significantly the metabolism of . About one-half (53.8 Ϯ 7.5%; n ϭ 4) of the latter total production was still recovered as H 14 
CO 3
Ϫ when, after incubation, 60 l of a solution of KCN (5.0 mM) in a HEPES buffer (20 mM, pH 7.4) were added, instead of 60 l of NaOH (0.1 N), to 50 l of the incubation medium containing 50 islets, before separation of H 14 CO 3 Ϫ and other radioactive acidic metabolites by anion-exchange chromatography. This indicates that, at the very least, one-half of the 14 CO 2 generated by the catabolism of D-[U- 14 C]glucose was converted to H 14 CO 3 Ϫ , presumably in the reaction catalyzed by carbonic anhydrase in intact islet cells. Indeed, it is quite likely that, in such a modified procedure, some H 14 CO 3 Ϫ present in the islets and/or surrounding incubation medium failed to be adequately recovered.
After correction for the recovery of H 14 CO 3 Ϫ , its production by islets over 90-min incubation in the presence of 16.7 mM D-glucose (mixed with a tracer amount of D-[U-
14 C]glucose) averaged 387.3 Ϯ 13.8 pmol/islet (n ϭ 20). As illustrated in Fig. 4 , it was decreased (P Ͻ 0.001) to 56.5 Ϯ 5.7% (n ϭ 6) and 46.5 Ϯ 2.8% (n ϭ 17) of such a control value in the presence of 5.0 and 10.0 mM acetazolamide, respectively, and to 51.6 Ϯ 6.7% (n ϭ 13) and 43.2 (Fig. 5) .
At the same 5 mM concentration, acetazolamide had little effect or in some cases induced a modest increase in [Ca 2ϩ ] i in islet cells exposed to 4 mM D-glucose but reversibly lowered [Ca 2ϩ ] i in the presence of 16 mM D-glucose (Fig. 6) . Acetazolamide (5 mM) did not appear to affect directly the activity of the volume-sensitive anion channel under whole cell recording conditions where the channel was activated by the use of a hypertonic pipette solution (Fig. 7) .
As shown in Fig. 8 , a rise in D-glucose concentration from 4 to 16 mM depolarized the cells and evoked electrical activity. Acetazolamide (5 mM) suppressed this electrical activity and repolarized the cells (Fig. 8, top trace) . In a number of cells, this repolarization was preceded by a transient period of silent depolarization (Fig. 8, bottom trace) . In either case, inhibition of electrical activity by 5 mM acetazolamide was essentially irreversible, at least within a "washout" period of 5-10 min. However, when acetazolamide was used at a concentration of 1 mM, the inhibitory effect of the drug was reversible following its removal from the bath solution (Fig. 9 ). In addition, no silent depolarization preceding repolarization was observed with this lower concentration of the drug.
When the cells were preincubated for 30 min with acetazolamide (5 mM), the depolarization otherwise caused by a rise in D-glucose concentration was severely blunted and was insufficient to result in electrical activity (not shown). When acetazolamide (5 mM) was applied to cells in the presence of 4 mM D-glucose, a transient depolarization sometimes accompanied by electrical activity was observed (Fig. 10) . In the continued presence of acetazolamide, a subsequent rise in D-glucose concentration to 16 mM resulted in a transient period of electrical activity before a period of silent depolarization (Fig. 10, bottom trace) .
DISCUSSION
The present data indicate that the specific activity of carbonic anhydrase in rat islet homogenates is about four times lower than that found in parotid cell homogenates. The relative extent of the inhibitory action of acetazolamide on carbonic anhydrase was also vastly different in islet and parotid cells, suggesting the participation of different isoenzymes in these two secretory cell types. Parotid glands indeed contain mainly carbonic anhydrase VI (16, 17, 24) , whereas the isoenzyme V prevails in pancreatic islets (19) .
The presence of the mitochondrial carbonic anhydrase V in insulin-producing islet cells may be relevant to the secretory activity of these cells in several respects. As already mentioned in the introduction, it may both provide HCO 3 Ϫ for pyruvate carboxylase and participate in the glucose-induced increase of mitochondrial Ca 2ϩ concentration (19) . It may also provide HCO 3 Ϫ for a bicarbonate-sensitive ATPase, previously shown to be present in rat pancreatic islets (23) , and play a role in the regulation of intracellular pH and ionic fluxes in the islet ␤-cells.
For instance, our findings suggest that carbonic anhydrase activity in islet homogenates could be sufficient to ensure full conversion of glucose-derived CO 2 to bicarbonate. Thus, at a concentration of HCO 3 Ϫ as low as 0.5 mM, well below the Table 1 ).
The secretory data obtained in a previous report (19) and in the present study support the view that the integrity of carbonic anhydrase activity is required to allow a normal stimulation of insulin release by D-glucose. In this respect, the results collected in islets exposed to NaN 3 are poorly contributive because of the lack of selectivity toward carbonic anhydrase. Indeed, NaN 3 inhibits several enzymes, such as catalase and iron enzymes, and uncouples phosphorylation. ] i in cells exposed to a high concentration of D-glucose. Incidentally, the high concentrations of carbonic anhydrase inhibitors required to decrease insulin secretion from intact islets, compared with those required to inhibit the activity of the enzyme in islet homogenates, could reflect the concentration dependency for the cellular uptake of these inhibitors.
The modest lowering of intracellular pH caused by acetazolamide could conceivably be related to the fact that it behaves as a weak acid (pK a close to 7.1) and, more likely, to the ionic consequences of carbonic anhydrase inhibition. In turn, the lowering of intracellular pH could be responsible for inhibition of glycolysis, as indicated by the decrease in the conversion of both D- [5- 3 H]glucose to 3 H 2 O and D-[U- 14 C]glucose to acidic 14 C-labeled metabolites (e.g., pyruvic and lactic acid). The fall in intracellular pH might also account for the occurrence of a transient depolarization and transient burst of spiking electrical activity in ␤-cells exposed to 4 mM D-glucose, with these effects being reminiscent of those otherwise seen after addition of 5-10 mM acetate.
Despite inhibition of both carbonic anhydrase in islet homogenates and HCO 3 Ϫ generation in intact islets, acetazolamide failed to affect significantly the total production of 14 CO 2 from D-[U-
14 C]glucose. Even NaN 3 only inhibited total 14 CO 2 production at the highest concentration (5.0 mM) tested in the present experiments. These findings suggest that any decrease in HCO 3 Ϫ production attributable to inhibition of carbonic anhydrase is soon masked by initiation of compensatory mechanisms, as also known to occur when considering the effect of carbonic anhydrase inhibitors on pulmonary CO 2 elimination (1).
The concentration-dependent dual effect of both acetazolamide and hydrochlorothiazide on glucose-stimulated insulin release, as illustrated in Fig. 3 , was found to coincide within the same range of concentrations with a dual effect of the same two drugs on 86 Rb outflow from prelabeled islets (unpublished observation). Moreover, the present experiments and unpublished results indicated that, at a given concentration, the effect of acetazolamide on selected islet variables may differ as a function of the concentration of D-glucose. For instance, at 4 mM D-glucose, acetazolamide (5 mM) caused, on occasion, a modest and gradual increase in [Ca 2ϩ ] i , whereas the sulfonamide obviously decreased [Ca 2ϩ ] i at 16 mM D-glucose. Likewise, at the same 5 mM concentration, acetazolamide provoked, in cells exposed to 4 mM D-glucose, a transient depolarization sometimes accompanied by electrical activity, while suppressing electrical activity in cells exposed to 16 mM D-glucose. These converging observations point to a pleiotropic response of ionic and secretory variables to acetazolamide as well as hydrochlorothiazide as a function of both the relative extent of carbonic anhydrase inhibition and the metabolic stimulation of islet cells.
In the liver, HCO 3 Ϫ generated by carbonic anhydrase serves as a substrate in the reactions catalyzed in the mitochondria by either pyruvate carboxylase or carbamylphosphate synthase 1 and, by doing so, contributes to both gluconeogenesis and the urea cycle. However, neither gluconeogenesis (22) nor the urea cycle (21) is operative in pancreatic islets. The relevance of carbonic anhydrase to the biochemical organization of islet cells remains, therefore, a matter of speculation.
As proposed by Parkkila et al. (19) , the perturbation of stimulus-secretion coupling in the ␤-cells exposed to acetazolamide may involve both impaired circulation in the pyruvatemalate shuttle and altered mitochondrial accumulation of Ca 2ϩ . Moreover, although no direct effect of acetazolamide on the activity of the volume-sensitive anion channel was apparent, a decreased generation of pyruvate and lactate from D-glucose could impair activation of the channel and subsequently alter the remodeling of Cl Ϫ fluxes, recently proposed to play a key role in the control of plasma membrane potential and electrical activity in the range (4 -16 mM) of insulinotropic D-glucose concentrations (4).
In conclusion, therefore, the present findings reinforce the view that carbonic anhydrase V plays a key role in the normal process of glucose-stimulated insulin secretion.
